AnaptysBio
is a clinical-stage biotechnology company that researches and commercializes anti-body therapeutics for the treatment of dermatological inflammatory diseases... Read moreAnaptysBio
is a clinical-stage biotechnology company that researches and commercializes anti-body therapeutics for the treatment of dermatological inflammatory diseases... Read more
News
Sep 01, 2026
StreetInsider
Press Release: AnaptysBio : Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
Aug 30, 2026
Investing.com
AnaptysBio: AnaptysBio earnings on deck: Can Jemperli offset revenue slide?
Aug 04, 2026
Americanbankingnews
AnaptysBio: AnaptysBio (ANAB) Projected to Post Quarterly Earnings on Wednesday
May 21, 2026
Zacks
AnaptysBio: Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?
May 14, 2026
Zacks
AnaptysBio: AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
May 12, 2026
Benzinga
AnaptysBio: Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update
May 11, 2026
Yahoo
AnaptysBio: Assessing AnaptysBio (ANAB) Valuation After Royalty Pivot Spinoff And Legal Outcome
May 11, 2026
Benzinga
AnaptysBio: AnaptysBio Appoints Christopher Murphy CFO
May 04, 2026
GlobeNewswire
Press Release: AnaptysBio : Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
Apr 28, 2026
FinanzNachrichten
AnaptysBio: Amended: GSK's Tesaro Provides Update On Anticipatory Breach Claim In AnaptysBio Litigation
AnaptysBio Competitors
1
2
3
4
5
6
7
8